Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,221 total articles
Rui Zhang, vice president, chief accounting officer and corporate controller of Photronics Inc., sold 4,556 shares of company stock on April 17, 2026, realizing proceeds of $212,765. The transaction occurred even as Photronics reported fiscal Q1 2026 results that beat analyst forecasts and announced investments in photomask production capacity in K…
Helen Louise Collins, chief medical officer at Enliven Therapeutics, sold 4,900 shares of the company's common stock on April 17, 2026, generating roughly $238,352. The sale was executed under a Rule 10b5-1 plan that Collins adopted in October 2025. Prior to the sale she exercised 5,000 options at $2.48 per share. Following these moves she holds 25…
Peter A. Thompson, a director at Sionna Therapeutics, sold about $2.47 million of the company’s common stock across two trades in mid-April under a pre-established 10b5-1 plan. The transactions, executed at prices above the current market, leave the reporting entity with nearly 3.0 million shares. The company has received bullish analyst coverage a…
OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC sold a combined 55,345 shares of Sionna Therapeutics (NASDAQ:SION) on April 17-18, 2026, generating $2,472,342 in proceeds under a pre-arranged 10b5-1 trading plan. The transactions occurred at prices between $44.52 and $44.68 per share. Following the sales, the OrbiMed entities collectively reta…
Chris Wren, vice president of operations at Planet 13 Holdings Inc. (OTC Markets: PLNH), sold 32,500 shares between April 17 and April 20, 2026, for roughly $4,904. The company's stock trades near a 52-week low even as Q4 2025 showed sequential revenue growth and an improved gross margin. After prior acquisition activity and the recent disposals, W…
Nextelligence, Inc., an entity controlled by FreeCast, Inc. Chief Executive Officer William A. Mobley, Jr., sold 506,250 shares of FreeCast Class A common stock on April 17, 2026 for $3,300,000 and later converted a promissory note into additional shares. The same week the company renewed a revolving convertible promissory note and FreeCast disclos…
George Kurtz, president and chief executive officer of CrowdStrike Holdings, sold 4,400 shares of Class A common stock across transactions on April 17 and April 20, 2026, for approximately $2.13 million. The sales were made under a pre-established 10b5-1 plan adopted January 6, 2026, at prices between $418.32 and $433.15 per share. InvestingPro dat…
Third Rock Ventures executed a planned sale of roughly $17.1 million in common stock of Rapport Therapeutics (RAPP) on April 17, 2026. The disposal of 426,005 shares occurred under a Rule 10b5-1 trading program adopted November 21, 2025. The transactions coincide with strong clinical data for Rapport’s RAP-219 program and several analyst Buy reiter…
Astera Labs CEO Mohan Jitendra disposed of 335,861 shares across multiple transactions on April 17 and April 20, 2026, generating $57,852,785 in proceeds under a Rule 10b5-1 plan. The sales were processed through a living trust for which Jitendra is trustee. The company’s shares have climbed 253% over the past year and trade at $192.02; recent quar…
Scott Gates, a director at Aehr Test Systems, sold a total of $5,660,000 of common stock on April 21, 2026, per a Securities and Exchange Commission filing. The transactions involved multiple block sales at prices between $91.00 and $95.00 per share. The moves leave Mr. Gates with a direct holding of 52,864 shares, including shares subject to unves…
Kenneth Duda, Arista Networks' president and chief technology officer, sold roughly $9.47 million of common stock on April 17, 2026 under a Rule 10b5-1 trading plan. The sales coincided with the shares trading close to a 52-week high and followed recent analyst upgrades and raised AI revenue targets for the company.
RA Capital Healthcare Fund LP, managed by RA Capital Management, L.P., sold 630,374 shares of Vor Biopharma Inc. (NASDAQ: VOR) common stock in April 2026 for roughly $10,174,787. The sales took place on April 17 and April 20 at weighted average prices of $16.28 and $15.77 per share, respectively. After the transactions the fund retains 2,567,245 sh…
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman exercised stock options and sold an equal number of shares under a prearranged trading plan on April 17, 2026. The transactions left Rodman with a direct holding of 69,792 shares. The insider activity comes as the stock has rallied over the past year and the company posts an earnings …
Llewellyn Lindsay Catherine, Lyft’s Chief Legal Officer and Corporate Secretary, executed a stock sale of 23,661 Class A shares on April 17, 2026 under a pre-established Rule 10b5-1 trading plan. The disposition totaled $354,915 and leaves her with 916,022 directly held shares. The move comes as Lyft’s shares trade below recent levels and amid comp…
MARA Holdings' CFO, Salman Hassan Khan, sold 16,000 shares under a pre-arranged Rule 10b5-1 plan on April 17, 2026, realizing $186,880. The company concurrently disclosed plans to repurchase roughly $1 billion of convertible senior notes at a discount, while Bitcoin’s rise supported gains in cryptocurrency-linked equities.
MARA Holdings Chief Executive Officer Frederick G. Thiel sold 27,505 shares of company stock on April 17, 2026 for $11.68 per share, netting $321,258. The transaction was carried out under a Rule 10b5-1 plan adopted May 28, 2025. The disclosure comes as MARA pursues repurchases of roughly $1 billion in convertible senior notes, funded via Bitcoin s…
Nowaid Zabi, general counsel of MARA Holdings, sold 42,090 shares on April 17, 2026 under a Rule 10b5-1 trading plan, generating roughly $505,080. The stock trades below the sale price and has been volatile. Separately, the company has arranged buybacks of approximately $1 billion in convertible senior notes, and recent strength in Bitcoin has supp…
Oasis Management Co Ltd. and affiliated entities sold 48,806 shares of Stratus Properties Inc. (NASDAQ: STRS) in transactions executed between April 17 and April 20, 2026, bringing the approximate proceeds to $1.46 million. The trades, executed at prices between $29.9043 and $30.0277 per share, follow a period in which the stock has risen 74% year-…
Brady Brewer, CEO, International at Starbucks Corp (SBUX), sold 588 shares on April 17, 2026 under a Rule 10b5-1 trading plan, generating $58,800 in proceeds. The transaction was reported on a Form 4 filed April 21, 2026. Analysts continue to offer divergent ratings and price targets ahead of the company’s fiscal second-quarter report.
Charles Collier, president of Roku Media, sold 205,807 Class A shares for $23,667,805 on April 17, 2026 under a pre-arranged 10b5-1 plan and simultaneously exercised 209,102 employee stock options costing $10,733,818. The moves occur as Roku approaches an earnings report, restructures its reporting segments, and announces it has exceeded 100 millio…
Laura Alber, president and CEO of Williams-Sonoma Inc. (WSM), sold 15,000 shares on April 17, 2026, under a Rule 10b5-1 plan adopted in October 2025. The sale amounted to $3,000,000 at $200.00 per share. Williams-Sonoma shares trade at $202.28 and have returned 49% over the past year. The company has recently seen analyst upgrades and reiterated Bu…
Vernon Rogers, AEHR Test Systems' Executive Vice President of Sales & Marketing, sold 5,000 shares on April 20, 2026 for $90.00 apiece, totaling $450,000. Following the transaction he directly holds 147,716 shares, including unvested restricted stock units. The company recently completed a $60 million at-the-market offering and won a record $41 mil…
Ouster Chief Technology Officer Mark Frichtl sold 120,000 shares of common stock across April 20-21, 2026, raising roughly $3.31 million under a previously established Rule 10b5-1 plan. The sales followed the exercise of 120,000 non-qualified stock options and leave Frichtl with 712,297 shares outstanding. The transactions occur as Ouster stock has…
Opaleye Management Inc., which owns about 10% of SANUWAVE Health, Inc. (NASDAQ:SNWV), reported sales of the company’s common shares totaling $336,982 executed between April 17 and April 21, 2026. The disposals included blocks from both Opaleye, L.P. and a separately managed account at prices clustered around $20.46 to $20.50 per share. The trades w…
Aehr Test Systems director Rhea J Posedel sold 8,787 shares on April 21, 2026, generating $843,756. The transaction occurred while the stock traded near its 52-week high, and follows company announcements including a $60 million at-the-market offering, a record $41 million production order, and quarterly results showing strong bookings.
